Skip to main content
Caplight Logo









Veminsyn

Veminsyn

Private
BeijingHealthcare & Life Scienceshttps://veminsyn.com/

Last Round

Series B

Extension

Sep 29, 2025

Est. Valuation

$100M

Total Funding Raised

$37.02M

Company Overview

Veminsyn is a biotechnology company that specializes in the research, development, and production of bio-based active ingredients for the personal care, cosmetics, and medical industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Fashion & Beauty, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Infrastructure

Keywords

synthetic biologybioactive ingredientsCRDMOcontract research development and manufacturingbio-manufacturingsynbioAI-driven drug discoverycellular digital twinsbiotech platformcosmetic ingredientsmolecular simulationplant cell manufacturingbiotech foundryskincare innovationbio-based materials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Veminsyn Comparables

Compare Veminsyn with similar companies based on industry and business-model similarity.

Veminsyn comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Debut
83%
Abolis
78%
Geltor
77%

Veminsyn Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionSep 29, 2025
Corporate FundingMay 23, 2025
Series AOct 18, 2022
AngelNov 1, 2021
Pre SeedNov 1, 2021

Veminsyn Investors

Notable investors and investment history

Veminsyn investors
InvestorRounds
CITIC CapitalSeries A
ZhenFundPre Seed, Series A, Angel
Hony CapitalSeries A, Pre Seed
BOLD (Business Opportunities for L'Oréal Development)Corporate Funding
Zhejiang Haibang Private Equity Fund Management Co., Ltd.Series B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2021

    Led by ZhenFund and Next Capital.

Veminsyn Filings

Explore SEC and related filing metadata, where available.

Veminsyn filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Veminsyn's valuation, stock price, and market status.

Is Veminsyn a public or private company?

Veminsyn is a private company.

What is the current stock price of Veminsyn?

Veminsyn is a private company with no public stock price. No recent secondary market data is available.

How much is Veminsyn worth (valuation)?

Valuation information for Veminsyn is not publicly available.

Can I buy Veminsyn stock?

Veminsyn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Veminsyn's last funding round?

Veminsyn's most recent funding round was Series B Extension on September 29, 2025.

Who are the main investors in Veminsyn?

Key investors in Veminsyn include CITIC Capital.

Will Veminsyn IPO soon?

No public IPO plans have been announced for Veminsyn.

How can I track Veminsyn secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Veminsyn's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Employee Range3
Year Founded2021
Last FundingSep 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?